Orphan Drugs & Rare Diseases Global Congress 2020 Americas will provide a unique platform for the convergence of stakeholders in the orphan drugs industry to discuss and network with top tier government, hospitals, pharmaceuticals, biopharmaceuticals, non-profit organizations, orphan drugs developers as well as regional and local manufacturers. Network with 120+ representative from pharma, biotech, patient groups/advocates, government, CROs and others…